Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous golimumab plus methotrexate versus placebo plus methotrexate in active rheumatoid arthritis despite methotrexate
2008-006064-11Phase 3Completed
- Sponsor
- Janssen Biologics B.V.
- Start
- Oct 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Golimumab IV + methotrexate with Placebo IV + methotrexate (2 arms). Primary endpoint: ACR20 response at Week 14. Started Oct 2009; status: completed.
02
Drugs
golimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-006064-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006064-11.